Vaccine Adverse Reaction
Conditions
Keywords
Vaccine, birth defect, adverse pregnancy outcomes
Brief summary
Uing data from a population based cohort in China, we will conduct retrospective cohort study to evaluate the risk of vaccine (e.g., HPV/influenza/rabies vaccine) administered during pregnancy (especially during first trimester) for adverse pregnancy outcomes (e.g., birth defects, preterm birth and low birth weight)
Detailed description
We will develop a vaccination cohort by linking population-based pregnancy registries (i.e., REPRESENT) with population-based vaccine databases. The researchers will use data from this cohort to examine vaccine use 90 days before the last menstrual period and throughout pregnancy. This study will investigate whether maternal vaccination during pregnancy is associated with the risk of adverse pregnancy outcomes. Poisson regression based on propensity scores will be used to estimate the relative risk. To ensure the robustness of the results, the researchers will perform several sensitivity analyses and negative control analyses, such as the risk of adverse pregnancy outcomes in pregnant women who have been vaccinated several times and pregnant women who have been vaccinated in mid and late pregnancy as negative control groups.
Interventions
BIOLOGICALHepatitis B vaccine, rabies vaccine, HPV vaccine, influenza vaccine
Exposure was defined as use of the vaccine 90 days before the last menstrual period and during pregnancy.
Sponsors
Sun Xin
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
14 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* All pregnant women in Xiamen who registry in our database.
Exclusion criteria
* Pregnant women who were lost to follow-up. Pregnant women exposed to related factors of known congenital malformation.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Birth defects | From pregnancy to 42 days after delivery | BDs were defined as any prenatal malformation (including structural, functional, or metabolic disorders) diagnosed through systematic ultrasound or genetic testing during pregnancy and any malformation diagnosed by clinicians within 42 days of birth，which were coded according to the International Classification of Diseases, Tenth Revision (ICD-10) (Q00-Q99). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Incidence of Adverse pregnancy outcomes | From pregnancy to 42 days after delivery | Including gestational diabetes, fetal distress, premature rupture of membranes, low birth weight and so on. |
Countries
China
Outcome results
None listed